Mesoblast Ltd. | Key People and Executives
Silviu Itescu
Chief Executive Officer, MD & Executive Director
Shawn Cline Tomasello
Director
Joseph R. Swedish
Director
Charlie Harrison
Secretary & Director
William Matt Burns
Non-Executive Vice Chairman
Brian Jamieson
Non-Executive Chairman
Donal Paul O'Dwyer
Independent Non-Executive Director
Eric A. Rose
Independent Non-Executive Director
Michael Robert Spooner
Independent Non-Executive Director
Silviu Itescu
Chief Executive Officer, MD & Executive Director
Joshua Muntner
Chief Financial Officer
Donna L. Skerrett
Chief Medical Officer
Paul Simmons
Head-Research & New Product Development
Michael Schuster
Head-Pharma Partnering
Jonathan Richard Symonds
Head-Corporate Finance & Strategy
Geraldine Storton
Head-Regulatory Affairs & Quality Management
Shawn Cline Tomasello
Director
Joseph R. Swedish
Director
Charlie Harrison
Secretary & Director
William Matt Burns
Non-Executive Vice Chairman
Julie Meldrum
Global Head-Corporate Communications
Schond Greenway
Investor Relations Contact
Peter T. Howard
General Counsel
Brian Jamieson
Non-Executive Chairman
Donal Paul O'Dwyer
Independent Non-Executive Director
Eric A. Rose
Independent Non-Executive Director
Michael Robert Spooner
Independent Non-Executive Director
| Address |
55 Collins Street
Melbourne Victoria (VIC) 3000
Australia
|
|
Employees
|
- |
| Website |
http://www.mesoblast.com |
| Updated |
07/08/2019 |
| Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target the cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Itescu Silviu on June 8, 2004 and is headquartered in Melbourne, Australia. |
